Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary.
Saved in:
| Title: | Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary. |
|---|---|
| Authors: | Moore, Kathleen N.1 (AUTHOR) kathleen-moore@ouhsc.edu, Lorusso, Domenica2 (AUTHOR), Oaknin, Ana3 (AUTHOR), Oza, Amit4 (AUTHOR), Colombo, Nicoletta5,6 (AUTHOR), Van Gorp, Toon7 (AUTHOR), O'Malley, David M.8 (AUTHOR), Banerjee, Susana9 (AUTHOR), Murphy, Conleth G.10 (AUTHOR), Harter, Philipp11 (AUTHOR), Konecny, Gottfried E.12 (AUTHOR), Pautier, Patricia13 (AUTHOR), Method, Michael14 (AUTHOR), Wang, Yuemei14 (AUTHOR), Coleman, Robert L.15 (AUTHOR), Birrer, Michael16 (AUTHOR), Matulonis, Ursula A.17 (AUTHOR) |
| Source: | Gynecologic Oncology. Dec2024, Vol. 191, p249-258. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
